229 related articles for article (PubMed ID: 24273392)
1. A Functional Proteomics Perspective of DBC1 as a Regulator of Transcription.
Joshi P; Quach OL; Giguere SS; Cristea IM
J Proteomics Bioinform; 2013 Apr; Suppl 2():. PubMed ID: 24273392
[TBL] [Abstract][Full Text] [Related]
2. The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene Expression.
Giguère SS; Guise AJ; Jean Beltran PM; Joshi PM; Greco TM; Quach OL; Kong J; Cristea IM
Mol Cell Proteomics; 2016 Mar; 15(3):791-809. PubMed ID: 26657080
[TBL] [Abstract][Full Text] [Related]
3. HDAC3 is negatively regulated by the nuclear protein DBC1.
Chini CC; Escande C; Nin V; Chini EN
J Biol Chem; 2010 Dec; 285(52):40830-7. PubMed ID: 21030595
[TBL] [Abstract][Full Text] [Related]
4. DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.
Kim HJ; Moon SJ; Hong S; Won HH; Kim JH
Nucleic Acids Res; 2022 Aug; 50(14):7873-7888. PubMed ID: 35801925
[TBL] [Abstract][Full Text] [Related]
5. A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo.
Santos L; Colman L; Contreras P; Chini CC; Carlomagno A; Leyva A; Bresque M; Marmisolle I; Quijano C; Durán R; Irigoín F; Prieto-Echagüe V; Vendelbo MH; Sotelo-Silveira JR; Chini EN; Badano JL; Calliari AJ; Escande C
Sci Rep; 2019 Oct; 9(1):14381. PubMed ID: 31591441
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy.
Yu EJ; Kim SH; Heo K; Ou CY; Stallcup MR; Kim JH
Nucleic Acids Res; 2011 Sep; 39(16):6932-43. PubMed ID: 21596782
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer metastasis suppressor 1 modulates SIRT1-dependent p53 deacetylation through interacting with DBC1.
Liu X; Ehmed E; Li B; Dou J; Qiao X; Jiang W; Yang X; Qiao S; Wu Y
Am J Cancer Res; 2016; 6(6):1441-9. PubMed ID: 27429856
[TBL] [Abstract][Full Text] [Related]
8. Deleted in breast cancer 1 (DBC1) protein regulates hepatic gluconeogenesis.
Nin V; Chini CC; Escande C; Capellini V; Chini EN
J Biol Chem; 2014 Feb; 289(9):5518-27. PubMed ID: 24415752
[TBL] [Abstract][Full Text] [Related]
9. DBC1/CCAR2 and CCAR1 Are Largely Disordered Proteins that Have Evolved from One Common Ancestor.
Brunquell J; Yuan J; Erwin A; Westerheide SD; Xue B
Biomed Res Int; 2014; 2014():418458. PubMed ID: 25610865
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of the deacetylase SIRT1 by DBC1.
Zhao W; Kruse JP; Tang Y; Jung SY; Qin J; Gu W
Nature; 2008 Jan; 451(7178):587-90. PubMed ID: 18235502
[TBL] [Abstract][Full Text] [Related]
11. Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.
Nin V; Escande C; Chini CC; Giri S; Camacho-Pereira J; Matalonga J; Lou Z; Chini EN
J Biol Chem; 2012 Jul; 287(28):23489-501. PubMed ID: 22553202
[TBL] [Abstract][Full Text] [Related]
12. Identification of DBC1 as a transcriptional repressor for BRCA1.
Hiraike H; Wada-Hiraike O; Nakagawa S; Koyama S; Miyamoto Y; Sone K; Tanikawa M; Tsuruga T; Nagasaka K; Matsumoto Y; Oda K; Shoji K; Fukuhara H; Saji S; Nakagawa K; Kato S; Yano T; Taketani Y
Br J Cancer; 2010 Mar; 102(6):1061-7. PubMed ID: 20160719
[TBL] [Abstract][Full Text] [Related]
13. hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1.
Zheng H; Yang L; Peng L; Izumi V; Koomen J; Seto E; Chen J
Mol Cell Biol; 2013 Dec; 33(24):4960-70. PubMed ID: 24126058
[TBL] [Abstract][Full Text] [Related]
14. A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer.
Kim HJ; Kim SH; Yu EJ; Seo WY; Kim JH
Oncogene; 2015 Aug; 34(34):4500-8. PubMed ID: 25417701
[TBL] [Abstract][Full Text] [Related]
15. Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer.
Hiraike H; Wada-Hiraike O; Nakagawa S; Saji S; Maeda D; Miyamoto Y; Sone K; Tanikawa M; Oda K; Nakagawa K; Yano T; Fukayama M; Taketani Y
Exp Ther Med; 2011 Nov; 2(6):1105-1109. PubMed ID: 22977628
[TBL] [Abstract][Full Text] [Related]
16. MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.
Pangon L; Mladenova D; Watkins L; Van Kralingen C; Currey N; Al-Sohaily S; Lecine P; Borg JP; Kohonen-Corish MR
Int J Cancer; 2015 Jan; 136(1):55-64. PubMed ID: 24824780
[TBL] [Abstract][Full Text] [Related]
17. DBC1 is a negative regulator of SIRT1.
Kim JE; Chen J; Lou Z
Nature; 2008 Jan; 451(7178):583-6. PubMed ID: 18235501
[TBL] [Abstract][Full Text] [Related]
18. DBC1 does not function as a negative regulator of SIRT1 in liver cancer.
Bae HJ; Chang YG; Noh JH; Kim JK; Eun JW; Jung KH; Kim MG; Shen Q; Ahn YM; Kwon SH; Park WS; Lee JY; Nam SW
Oncol Lett; 2012 Nov; 4(5):873-877. PubMed ID: 23162614
[TBL] [Abstract][Full Text] [Related]
19. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D
J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644
[TBL] [Abstract][Full Text] [Related]
20. Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice.
Escande C; Chini CC; Nin V; Dykhouse KM; Novak CM; Levine J; van Deursen J; Gores GJ; Chen J; Lou Z; Chini EN
J Clin Invest; 2010 Feb; 120(2):545-58. PubMed ID: 20071779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
